Final Decision on Avastin's Indication for Breast Cancer Must Satisfy the Public

August 29, 2011
The Pharmaceutical Affairs and Food Sanitation Council's (PAFSC) Second Committee on New Drugs has decided to continue discussions on whether to recommend an additional indication of breast cancer for the anticancer drug Avastin (bevacizumab; Chugai Pharmaceutical). Some Committee members pointed...read more